NovaBay Pharmaceuticals, Inc.NovaBay Pharmaceuticals, Inc.NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc.

No trades
See on Supercharts
Market capitalization
‪2.87 M‬USD
−3.3150USD
‪−9.64 M‬USD
‪14.73 M‬USD
‪35.87 M‬
Beta (1Y)
0.71

About NovaBay Pharmaceuticals, Inc.

CEO
Justin M. Hall
Headquarters
Emeryville
Employees (FY)
26
Founded
2000
ISIN
US66987P3001
FIGI
BBG000PVPJT3
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NBY is 0.08 USD — it has increased by 4.28% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange NovaBay Pharmaceuticals, Inc. stocks are traded under the ticker NBY.
NovaBay Pharmaceuticals, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for NovaBay Pharmaceuticals, Inc. has a max estimate of 3.20 USD and a min estimate of 2.00 USD.
NBY earnings for the last quarter are −0.37 USD whereas the estimation was −0.41 USD which accounts for 8.64% surprise. Estimated earnings for the next quarter are −0.30 USD. See more details about NovaBay Pharmaceuticals, Inc. earnings.
NovaBay Pharmaceuticals, Inc. revenue for the last quarter amounts to ‪3.27 M‬ USD despite the estimated figure of ‪3.55 M‬ USD. In the next quarter revenue is expected to reach ‪3.40 M‬ USD.
Yes, you can track NovaBay Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, NBY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NovaBay Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
NBY reached its all-time high on Oct 26, 2007 with the price of 3718.75 USD, and its all-time low was 0.08 USD and was reached on Apr 9, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 26.00 employees. See our rating of the largest employees — is NovaBay Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NovaBay Pharmaceuticals, Inc. EBITDA is ‪−4.80 M‬ USD, and current EBITDA margin is −32.60%. See more stats in NovaBay Pharmaceuticals, Inc. financial statements.